?
Mcdew Darren W
Director
Abbott Laboratories
US, North Chicago [HQ]
CIK
1787479
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
19,552
Price per Share :
$95.40
Equivalence :
$1,865,260.80
Transaction History
-
A19,552 Shares After TransactionValue : $n/a$0.0Transaction Date : 04/16/24
-
Footnotes
-
-
Footnotes:#1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest on April 15, 2025, subject to deferral, and have no expiration date.
-
A17,373 Shares After TransactionValue : $n/a$0.0Transaction Date : 04/18/23
-
Footnotes
-
-
Footnotes:#1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest on April 17, 2024, subject to deferral, and have no expiration date.
-
A8,757 Shares After TransactionValue : $n/a$0.0Transaction Date : 04/26/24
-
Footnotes
-
-
Footnotes:#1 These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
-
A1,165 Shares After TransactionValue : $n/a$0.0Transaction Date : 05/07/24
-
Footnotes
-
-
Footnotes:#1 Restricted Stock Units granted under the 2022 Long-Term Incentive Plan, which will vest on the first anniversary of the grant date.